论文部分内容阅读
目的探讨选择性肝动脉栓塞术在肝血管瘤患者中的应用情况。方法选择2011年3月至2013年2月间诊治的32例肝血管瘤患者作为研究对象,均采用选择性肝动脉栓塞术治疗,平阳霉素碘油乳剂栓塞瘤体,明胶海绵栓塞供血动脉,随访12个月,观察患者的临床治疗效果。结果选择性肝动脉栓塞术操作成功率为100.0%,且术后无严重并发症发生。随访6个月时,患者的治疗有效率为93.8%,血管瘤直径由术前的(9.2±1.9)cm缩小至(6.9±1.7)cm,差异有统计学意义(P<0.01);生活质量评分也明显改善,差异有统计学意义(P<0.05)。随访12个月时,患者的治疗有效率为96.9%;血管瘤直径缩小至(3.2±1.0)cm,与术前比较,差异有统计学意义(P<0.01);生活质量评分进一步明显改善,差异有统计学意义(P<0.01)。结论选择性肝动脉栓塞术在肝血管瘤患者中的应用效果满意且安全性好,能够明显缩小血管瘤,提高患者的生活质量。
Objective To explore the application of selective hepatic artery embolization in patients with hepatic hemangiomas. Methods Thirty-two patients with hepatic hemangiomas diagnosed and treated between March 2011 and February 2013 were enrolled in this study. Selective hepatic arterial embolization was used to treat the patients. The bleomycin-lipiodol emulsion embolization tumor, the gelatin sponge embolization of the feeding artery, The patients were followed up for 12 months to observe the clinical effect of the patients. Results The success rate of selective hepatic arterial embolization was 100.0%, and no serious complications occurred after operation. At 6 months of follow-up, the effective rate of treatment was 93.8%. The diameter of hemangioma decreased from (9.2 ± 1.9) cm to (6.9 ± 1.7) cm before surgery, with significant difference (P <0.01) The score also significantly improved, the difference was statistically significant (P <0.05). The follow-up of 12 months, the patient’s treatment efficiency was 96.9%; hemangioma diameter reduced to (3.2 ± 1.0) cm, compared with preoperative, the difference was statistically significant (P <0.01); quality of life scores were further significantly improved, The difference was statistically significant (P <0.01). Conclusion Selective hepatic arterial embolization in patients with hepatic hemangiomas with satisfactory results and good safety, can significantly reduce the hemangioma and improve the quality of life of patients.